Such research will shed light on the roles of homologous genes in humans with metabolic conditions as hyperuricemia and gout and on the effects of drugs used to treat these conditions, such as the xanthine dehydrogenase inhibitor drug allopurinol, which is widely used to prevent UA production. Here, XDH is linked to hyperuricemia.